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A Cold-Inducible Coactivator
of Nuclear Receptors
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widely expressed b-1 and b-2 and the fat-selective b-3
receptor. At a cellular level, the key processes of adap-
tive thermogenesis are the biogenesis of mitochondria
and the expression of genes that control the rate of
fuel oxidation and ATP synthesis in those mitochondria
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membrane of the mitochondria where they facilitate pro-Department of Medicine
ton transport, dissipating the proton gradient linked toUniversity of Chicago
the oxidation of metabolic fuels, thus generating heat.Chicago, Illinois 60637
Three UCPs have been reported. UCP-1 is specific for
brown adipose cells (Jacobsson et al., 1985; Bouillaud
et al., 1986). UCP-2 is expressed widely (Fleury et al.,Summary
1997; Gimeno et al., 1997), while UCP-3 is expressed
primarily in skeletal muscle and brown fat (Boss et al.,Adaptive thermogenesis is an important component of
1997; Gong et al., 1997; Vidal-Puig et al., 1997). Theenergy homeostasis and a metabolic defense against
relative contributions of these three molecules to bothobesity. We have cloned anovel transcriptional coacti-
adaptive thermogenesis and basal metabolic rate arevator of nuclear receptors, termed PGC-1, from a
under active study.brown fat cDNA library. PGC-1 mRNA expression is
While many of the genes that function directly in adap-dramatically elevated upon cold exposure of mice in
tive thermogenesis are being uncovered, very little isboth brown fat and skeletal muscle, key thermogenic
known about the transcriptional regulation of this pro-tissues. PGC-1 greatly increases the transcriptional
cess. One promising approach may be through studyingactivity of PPARg and the thyroid hormone receptor
differentiation and gene expression in the cell type spe-on the uncoupling protein (UCP-1) promoter. Ectopic
cialized to carry out adaptive thermogenesis: brown fatexpression of PGC-1 in white adipose cells activates
cells. These cells function specifically to dissipate en-expression of UCP-1 and key mitochondrial enzymes
ergy in the form of heat in response to cold or overfeed-of the respiratory chain, and increases the cellular
ing. The role of brown adipose tissue (BAT) as a defensecontent of mitochondrial DNA. These results indicate
against obesity has been clearly illustrated through tar-that PGC-1 plays a key role in linking nuclear receptors
geted ablation of this tissue; BAT-less mice develop ato the transcriptional program of adaptive thermo-
severe obesity with insulin resistance and other meta-genesis.
bolic abnormalities typical of obesity (Lowell et al.,1993).
Analysis of the role of BAT in humans and other largeIntroduction
mammals has proven more complex. Adult humans do
not have well-defined BAT depots, but UCP-1 expres-
Obesity, an excessive accumulation of adipose tissue,
sion can be detected in white adipose tissue (WAT)
affects nearly 30% of adults in the US. This high preva-
depots, suggesting that brown fat cells may be dis-
lence has led to increases in the medical conditions that
persed among white fat cells (Garruti and Ricquier,
often accompany obesity, especially diabetes (NIDDM),
1992). Chronic exposure to b-3-adrenergic agonists
cardiovascular disorders, and certain cancers. Obesity causes BAT hypertrophy in both rodents and larger
results from a chronic imbalance between energy intake
mammals, including humans, and has thermogenic,
(feeding) and energy expenditure. Energy expenditure
antiobesity effects (Champigny et al., 1991).
has several major components including basal metabo-
Recent data has pointed to an important role for sev-
lism, physical activity, and adaptive (nonshivering) ther- eral nuclear hormone receptors in the differentiation of
mogenesis. This latter process refers to energy that is brown fat cells and UCP-1 gene expression, particularly
dissipated in response to changing environmental con- the thyroid hormone receptor (TR) (Silva, 1995) and
ditions, most notably exposure to cold or excessive ca- PPARg (Sears et al., 1996). Thyroid hormone is required
loric intake (so-called diet-induced thermogenesis). for brown fat cell differentiation, and the UCP-1 pro-
Adaptive thermogenesis is regulated by at least two moter contains a binding site for TR (Cassard-Doulcier
major hormonal effectors: b-adrenergic agents and thy- et al., 1994). The potential involvement of PPARg in these
roid hormone (Himms-Hagen, 1989). Both of these hor- processes is particularly interesting because the PPARg/
mone systems have an impact on energy dissipation RXR heterodimer has been shown to be a major regula-
through actions on the number and function of mito- tor of fat cell±specific gene regulation and differentiation
chondria, especially in brown fat and skeletal muscle. in white adipose cells (Tontonoz et al., 1994a; Spiegel-
Thyroid hormone is known to act through its specific man and Flier, 1996). Recently, activation of PPARg by
nuclear receptors while the b-adrenergic agents func- synthetic ligands, the antidiabetic thiazolidinediones
tion through the cell surface b-adrenergic receptors, the (TZDs), has been shown to promote the differentiation
of brown fat precursor cells. These agents also cause
a hypertrophy of BAT when given in vivo to obese rats³To whom correspondence should be addressed.
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Figure 1. Analysis of PGC-1 Sequence
(A) Amino acid sequence of PGC-1. Shown
by underlining are the SR domains (aa 565±
598 and 617±631),RNA-binding (aa 677±709),
three consensus sites for phosphorylating
protein kinase A (aa 238±241, 373±376, and
655±658), and an LXXLL motif (aa 142±146).
(B) Schematic representation of the structure
of PGC-1. Arrows indicate possible protein
kinase A phosphorylation sites [(R,K)2x(ST)].
Gray box indicates the SR rich region domain
and black box indicates the RNA-binding
domain.
(Foellmi-Adams et al., 1996; Tai et al., 1996). While these more detailed study. We termed the protein encoded
by this cDNA PPAR Gamma Coactivator (PGC)-1.data have indicated a role for PPARg in brown fat differ-
entiation, it is also clear that this transcription factor A 3 kb PGC-1 cDNA containing theentire open reading
frame was obtained by screening an oligo dT lZAPcannot per se determine whether fat cells proceed along
the energy storage (white) or energy dissipation (brown) cDNA library made from HIB-1B cells. This encodes a
protein of 795 amino acids with a predicted molecularpathway. One clue to this issue may have come from a
recent series of studies that identified a functional bind- mass of 92 kDa (Figure 1A). Databank searches indicate
that PGC-1 represents a novel protein with no closeing site for PPARg/RXR in the brown fat selective en-
hancer of the Ucp-1 gene (Sears et al., 1996). Transacti- homologs in any databases except expressed sequence
tag (EST) databases. It does, however, contain recogniz-vation studies showed that PPARg could activate this
element, but only in brown fat cells, not in fibroblasts. able peptide motifs. As shown in Figures 1A and 1B,
PGC-1 contains a putative RNA-binding motif (aa 677±This suggested that PPARg might have a regulated co-
factor that allows it to function specifically in the context 709) and two so-called SR domains, regions that are
rich in serine and arginine residues (aa 565±598 andof brown fat cell lineage and the thermogenic genes that
characterize this cell type. In this report, we describe 617±631). Interestingly, proteins containing paired RNA-
binding motifs and SR domains have been shown tothe cloning and characterization of a novel coactivator of
PPARg and other nuclear receptors from brown adipose interact with the C-terminal domain (CTD) of RNA poly-
merase II (Yuryev et al., 1996). Except for these twocells. This factor, termed PGC-1, is dramatically induced
in both brown fat and skeletal muscle by exposure of regions,however, PGC-1 shares no other sequence sim-
ilarity with other proteins that contain these domains.animals to cold and can regulate several key mitochon-
drial genes that contribute to the program of adaptive In addition to these domains, PGC-1 also contains three
consensus sites for phosphorylation by protein kinasethermogenesis.
A. However, no significant homology was discovered
between PGC-1 and any known coactivator of nuclear
Results
receptors. PGC-1 does, however, contain one LXXLL
motif (aa 142±146), recently identified as an element that
Isolation of PGC-1, a Novel
can mediate nuclear receptor±coactivator interactions
PPARg Binding Protein
(Heery et al., 1997; Torchia et al., 1997).
We used a yeast two-hybrid system to identify PPARg-
interacting proteins from murine brown fat cells (see
Experimental Procedures). A screen of 1 3 106 primary PGC-1 Interacts Specifically with PPARg and
Other Members of the Nuclear Hormonetransformants made using cDNAs prepared from HIB
1B brown fat cells yielded about 130 clones. These were Receptor Superfamily
To investigate the interaction between PGC-1 andthen analyzed for preferential expression in brown ver-
sus white fat with RNA blots. One partial cDNA whose PPARg first observed in yeast, GST-purified fusion pro-
teins were immobilized on glutathione agarose beadsopen reading frame encodes a novel protein received
Thermogenic Coactivator of Nuclear Receptors
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Figure 2. Interaction of PGC-1 with Several
Nuclear Receptors
(A) Interaction between proteins in vitro. Con-
trol GST protein alone or PGC-1 (aa 36±797)
fused to GST were immobilized on gluta-
thione agarose beads and incubated with
different in vitro±translated [35S]methionine-
labeled nuclear receptors and appropriate
ligands or vehicle (see Experimental Proce-
dures for details). For PPARg, BRL 49653 was
used at 10 mM; for TRb, T3 was used at 1 mM;
for RXRa, 9-cis RA was used at 1 mM; for
RARa, RA was used at 1 mM; and for ERa,
estradiol was used at 1 mM. After the beads
were washed, bound proteins were eluted
and resolved by SDS-PAGE and visualized
by autoradiography.
(B) Interaction between PGC-1 and PPARg in
cells. Vectors expressing HA-tagged PGC-1
and PPARg were transfected into COS cells.
Ligands pioglitazone (5 mM), 9-cis RA (1 mM),
and 8-Br-cAMP (1 mM) were added 3 hr be-
fore cells were harvested. Cells extracts and
Western blots were performed as described
in the Experimental Procedures.
(C) PGC-1 is localized to the nucleus. The full-length PGC-1 was fused to a green fluorescent protein (GFP), and this was expressed in COS
cells with a pEGFP expression vector. Fluorescent GFP-PGC-1 was visualized with a Nikon Diaphot 200 microscope.
and incubated with in vitro±translated, [35S]methionine- (Kamei et al., 1996) and involves an LXXLL motif in
labeled PPARg and other nuclear receptors. As shown the coactivators and the C-terminal AF-2 domain in the
in Figure 2A, PPARg associates with GST±PGC-1 but receptors (Heery et al., 1997; Torchia et al., 1997). To
fails to bind to the control GST protein. This interaction identify the domains responsible for PGC-1±PPARg in-
is not ligand-dependent, in that addition of BRL49653 teractions, we first generated different C-terminal dele-
(a thiazolidinedione ligand for PPARg) at 10 mM does tions of PGC-1 as reticulocyte translation products and
not significantly alter this binding. A similar lack of ligand mixed these with a GST-PPARg fusion protein. As shown
dependence for this interaction was seen when bacteri- in Figures 3A±3C, 35% of the input of both the full-length
ally expressed PPARg was immobilized on beads and PGC-1(1±797) and the 1±675 deletion is bound to the
used with reticulocyte-translated PGC-1 (data not shown). immobilized PPARg. The binding of PGC-1 1±503, which
The TRb also binds specifically to PGC-1, though in this lacks the SR and RNA-binding domains, is modestly
case ligand (T3) addition causes a 2- to 3-fold increase decreased to 18%. A similar level of binding can be seen
in binding. A strong ligand-dependent binding is seen for PGC-1 1±403 and 1±338. However, PGC-1 1±292,
between PGC-1 and the retinoic acid (RA) receptor, and which still contains the LXXLL motif, completely loses
between PGC-1 and the estrogen receptor (ERa). In the ability to interact with PPARg. As shown in Figure
contrast, little or no binding is seen between PGC-1 and 1, residues 292±338 contain no distinct domains known
the retinoid X receptor (RXRa), with or without ligand to mediate protein±protein interaction, though it is very
addition. These data indicate that PGC-1 interacts spe- rich in proline residues.
cifically with PPARg and several other nuclear receptors
Most of the nuclear hormone receptor coactivators
in vitro. There is a broad range of dependence on ligand
identified to date interact with the C-terminal AF-2 do-
for these interactions, fromno liganddependence (PPARg)
main, which is responsible for ligand-dependent tran-to a strong dependence on ligand addition (RARa).
scriptional activation. To determine if PGC-1 also inter-The interaction between PPARg and PGC-1 can also
acts with this part of PPARg, we used several deletionsbe seen in mammalian cells. Even in the absence of
of PPARg prepared as GST fusion proteins and com-added ligand, an association is observed between these
bined them with in vitro±translated PGC-1. Figure 4two proteins in immunoprecipitation assays (Figure 2B).
shows that amino acids 181±505 of PPARg (the originalWhen cells are treated with pioglitazone (a PPARg li-
fragment used in the yeast two-hybrid screen) interactgand), a very modest increase in association is ob-
strongly with PGC-1, pulling down 23% of the input. Onserved. To ask whether PGC-1 does indeed reside in the
the other hand, a further deletion of 45 amino acidscell nucleus, we constructed a fusion protein between
(228±505) is not able to bind to full-length PGC-1. BothPGC-1 and green fluorescent protein (GFP). When GFP±
of these PPARg deletions were able to bind SRC-1 (dataPGC-1 is expressed in COS cells, it is observed entirely
not shown), indicating that they have not lost their gen-in the cell nucleus (Figure 2C).
eral ability to interact with other proteins. These data
demonstrate that PPARg utilizes part of its DNA-bindingIdentification of the Domains that Mediate
and hinge domains to bind PGC-1. It apparently doesthe PGC-1±PPARg Interaction
not interact through the C-terminal AF-2 domain thatThe interaction between nuclear receptors and certain
coactivators such as SRC-1 or CBP is ligand dependent docks other coactivators such as SRC-1 and CBP.
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Figure 4. Mapping the Domain of PPARg Interacting with PGC-1
(A) Full-length, [35S]methionine-labeled PGC-1 was prepared inretic-
ulocyte lysates and was incubated with various deletions of PPARg
prepared as GST fusion proteins. The pull-down assays were done
exactly as in Figure 3A.
(B) Diagram of different PPARg deletions with the corresponding
percentage binding to PGC-1. Quantitative analysis was done as in
Figure 3.
muscle (Himms-Hagen, 1989). As shown in Figure 5B,
PGC-1 is highly induced (about 30- to 50-fold) in brown
fat after 3 hror 12 hrat 48C, in parallel with UCP-1 mRNA.
Figure 3 also shows that PGC-1 mRNA expression in
white fat and liver remains undetectable after cold expo-
Figure 3. Mapping the Domain of PGC-1 Interacting with PPARg sure. Although PGC-1 mRNA expression is not detect-
(A) Input of deleted PGC-1 proteins. Deletions of PGC-1 were made able in skeletal muscle from mice kept at ambient tem-
using specific rectriction sites in the PGC-1 cDNA cloned in pBlue- perature, exposure of mice to cold for 12 hr induces
script. The following restriction enzymes were used for these dele-
expression of the Pgc-1 gene in this tissue. Heart andtions: full-length XhoI (aa 1±797), HaeII (aa 1±675), NcoI (aa 1±503),
kidney, which express PGC-1 mRNA at room tempera-XbaI (aa 1±403), KpnI (aa 1±338), and StuI (aa 1±292). These were
ture, do not elevate this expression upon cold exposure.then translated in vitro with an [35S]methionine-label. One microliter
of each in vitro translation reaction was resolved by SDS-PAGE and Figure 5C illustrates that the cold-induced expression
autoradigoraphed. of PGC-1 in the brown fat of these mice also correlates
(B) PPARg interactions with PGC-1 deletions. A control GST fusion other key mitochondrial proteins including ATP-synthe-
protein (V) or a GST fusion with PPARg (P) was incubated with the
tase (b subunit) and cytochrome c-oxidase subunitsdifferent PGC-1 deletion shown in (A). Incubations, washing, and
(COX II and COX IV). Although chronic cold exposureanalysis were done as in Figure 2, without addition of ligand. The
has been reported to lead to elevated activities for thesepercentage of binding was quantified by phosphorimage analysis.
(C) Diagram of different PGC-1 deletions with the corresponding mitochondrial proteins in skeletal muscle (Bourhim et
percentage of input material that bound to PPARg. The LXXLL motif al., 1990), no induction of mRNA for ATP-synthetase,
is located at amino acid residues 142±146. The black box corre- COX II, or COX IV can be seen in muscle with this rela-
sponds to the PPARg-binding domain of PGC-1 (aa 292±338). tively brief exposure to cold.
Cold is sensed in the central nervous system and
results in increased sympathetic output to peripheralExpression of PGC-1 mRNA Is Induced by Exposure
to Cold or a b-Adrenergic Agonist tissues, including muscle and brown fat (see Himms-
Hagen, 1989, and references therein). Cold exposureThe pattern of PGC-1 expression was determined by
Northern blot analysis of mRNA prepared from a variety can bemimicked, in terms of brown adipocyte precursor
cell growth and the induction of UCP-1, by exposure ofof mouse tissues. As shown in Figure 5A, using mice
kept at ambient temperature (248C), a major species cultured brown fat cells to b-adrenergic agonists (Rehn-
mark et al., 1990). To determine if Pgc-1 gene expressionof approximately 5 kb is observed in brown fat, heart,
kidney, and brain. In addition, a minor species of approx- is also sensitive to b-adrenergic agonists, HIB1B brown
fat cells were treated with isoproterenol, a nonsubtypeimately 8 kb is also observed in all of these tissues. In
contrast, no PGC-1 mRNA expression is observed from selective b agonist, for 10 hr. As shown in Figure 6, this
results in a sharp increase in both PGC-1 mRNA andwhite fat, lung, skeletal muscle, liver, testes, or spleen.
Exposure to cold is a classical inducer of adaptive UCP-1 mRNA. Exposure of brown fat cells to 9-cis reti-
noic acid has previously been shown to potentiate thethermogenesis, especially in brown fat and skeletal
Thermogenic Coactivator of Nuclear Receptors
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Figure 6. Expression of PGC-1 mRNA Is Induced by b-Adrenergic
Agonists
HIB 1B brown fat preadipocytes were differentiated as described in
the Experimental Procedures.After 6 days, cells were approximately
80% differentiated. They were then treated with isoproterenol (1
mM) for 6 hr and 9-cis retinoic acid (1 mM) for 24 hr. Total cellular
RNA was isolated and analyzed using PGC-1 and UCP-1 cDNA
probes.
or the TR. The UCP-1 promoter has been shown to
have binding sites for both PPARg and the TR (Cassard-
Doulcier et al., 1994; Sears et al., 1996). Figure 7A shows
that the PPARg/RXRa combination transactivates the
UCP-1 promoter very poorly in fibroblasts, as shown by
Sears et al. (1996). The addition of a cocktail of 8-bro-
mocyclic AMP, 9-cis retinoic acid, and troglitazone, a
PPARg ligand, has been used previously to give an opti-
mal induction of UCP-1 in brown fat cells (Silva and
Rabelo, 1997). These agents cause only a small increase
Figure 5. Expression of PGC-1 mRNA in Mouse Tissues and Induc- in the transcriptional activity of the PPARg/RXR combi-
tion by Exposure to Cold nation above that seen with the control vector. The ex-
(A) Northern blot analysis of total RNA isolated from the indicated pression of PGC-1 alone does not induce transcriptional
mouse tissues using radiolabeled PGC-1 cDNA as a probe. Ethidium activity above the control vector. However, the addition
bromide±stained 28S RNA is shown as a control for quantity of RNA.
of PGC-1 to the PPARg/RXRa combination causes aArrows indicate the size of the PGC-1 bands.
very dramatic increase in transcriptional activity that is(B) PGC-1 and UCP-1 mRNAs are induced in brown fat during cold
dependent on the ligand cocktail (see below). Similarly,exposure. Mice were maintained at 48C for 3 or 12 hr, sacrificed,
and tissues were dissected and used for preparation of RNA. Ten TRb/RXRa combination alone induced very little tran-
mice were pooled for each sample. scriptional activity, even when stimulated with a ligand
(C) mRNA analysis of PGC-1 and genes of mitochondrial function cocktail including T3 (Figure 7B). However, the combina-in different mouse tissues after cold exposure. Animal treatment
tion of PGC-1 with the TRb/RXRa pair induced powerfulwas as in (B). Probes used for hybridization were PGC-1, UCP-1,
transactivation, again in a ligand-dependent manner.ATP synthetase (b subunit), cytochrome c-oxidase II (COX-II), and
These results clearly indicate that PGC-1 can functioncytochrome c-oxidase IV (COX-IV).
as a potent transcriptional coactivator for PPARg and
the TR. It is interesting that the optimal transcriptional
response is seen when PPARg ligand is added, despiteeffects of b agonists to induce UCP-1 expression (Puig-
server et al., 1996). Addition of this retinoid (which acti- the fact that the binding of PGC-1 and PPARg is not
ligand dependent. It is likely that this results from simul-vates both RXR and RAR) and isoproterenol to the
HIB1B cells results in a small, further increase in both taneous, ligand-dependent dockingof another coactiva-
tor, such as SRC-1, CBP, or others (see Discussion).PGC-1 and UCP-1 expression. These results suggest
that b-adrenergic agonists may play an important role The role of different hormones and ligands used to
achieve maximal transcriptional activation with PPARgin mediating the effects of cold on the induction of both
UCP-1 and PGC-1. and PGC-1 is dissected in Figure 7C. The individual
componentsÐtroglitazone (trog.), 9 cis-retinoic acid
(9cRA), and 8-bromo cyclic AMP (cAMP)Ðeach stimu-PGC-1 Is a Powerful Transcriptional
Coactivator for PPARg and the TR late a 2- to 4-fold increase in transcriptional activity.
However, the most robust responses are seen whenTo test for transcriptional coactivation by PGC-1, we
utilized the UCP-1 promoter in combination with PPARg they are used in combination. The synergistic effect of
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has its own transcriptional activation domain or contains
some activity that might unmask or augment the tran-
scriptional activator properties of the nuclear receptors.
To approach this, we made a fusion protein between
PGC-1 and the DNA-binding domain (DBD) of GAL4 and
assayed transcription through a GAL4 DNA binding tar-
get sequence, the UAS. As shown in Figure 7D, PGC-1
can activate transcription readily when tethered to DNA
by the GAL4 DBD. For comparison, the results obtained
by fusion of the GAL4 DBD with another coactivator of
nuclear receptors, SRC-1, is shown. Thus, PGC-1 does
not absolutely require docking to a nuclear receptor
to demonstrate transcriptional activation function; it is
likely that its interaction with these receptors serves
primarily to bring PGC-1 to appropriate DNA sites.
Ectopic Expression of PGC-1 Induces Molecular
Components of Adaptive Thermogenesis
To examine directly the ability of PGC-1 to regulate
the genes of adaptive thermogenesis, we have utilized
retroviral vectors to express this protein in white fat
precursor cells, and 3T3-F442A preadipocytes were then
stimulated to differentiate. The cells were subsequently
maintained for 4 days in medium containing 10 or 100 nM
T3. To induce UCP-1 expression, 1 mM 8-bromo-cAMP
and 1 mM 9-cis-retinoic acid were added to the medium,
and total RNA was extracted from the cells 6 hr later.
As shown in Figure 8A, PGC-1 mRNA was barely detect-
able in these white fat cells infected with empty vectors
but was obvious in cells infected with the viruses con-
taining the PGC-1 cDNA. The expression of this mRNA
in the cultured cells was approximately 6% of that seen
Figure 7. PGC-1 Powerfully Stimulates the Transactivation of the in the brown fat of cold exposed mice (data not shown).
UCP-1 Promoter by PPARg and the TR mRNA for UCP-1, the classic marker of brown fat cells
(A) PGC-1 coactivates the transcriptional activity of PPARg/RXRa. that is encoded in the cell nucleus, is barely detectable
A CAT reporter gene linked to the UCP-1 promoter (23740/1110 in the control 3T3-F442A cells but is significantly in-
kb) was transfected into Rat1 IR cells along with expression vectors duced in the cells expressing PGC-1. mRNA for ATP
for PPARg, RXRa, and PGC-1 (see Experimental Procedures). Cells
synthetase, a key mitochondrial protein involved in oxi-were changed to medium containing 0.5% BSA 12 hr after transfec-
dative phosphorylation that is also encoded in the nu-tion and the following ligands were added: 10 mM troglitazone and
cleus, is likewise increased in the cells expressing1 mM 9-cis-retinoic acid for 24 hr treatment, while 1 mM 8-bromo
cAMP was added for the last 12 hr. Cells were harvested 36 hr after PGC-1. The mitochondrial respiratory enzyme cyto-
transfection. Results from CAT assays were controlled for transfec- chrome c-oxidase subunits COX II and IV are encoded
tion efficiency by cotransfection of a b-galactosidase reporter gene in the mitochondrial and nuclear genome, respectively.
under the control of the CMV promoter.
Both of these mRNAs increase 2- to 3-fold in the cells(B) PGC-1 activates the transcriptional activity of TRb/RXRa. CAT
ectopically expressing PGC-1. For comparison, wereporter assays were done as in (A), except that 1 mM T3 was used
show expression of aP2, a white and brown fat cell geneinstead of troglitazone.
(C) Ligand/hormone dependence of PGC-1-stimulated activity from not linked to thermogenesis, and 36B4, a ribosomal pro-
the UCP-1 promoter. CAT reporter gene assays were performed as tein used as a loading control. These data clearly dem-
described in (A), using PPARg, RXRa, and PGC-1 vectors. The fold onstrate that PGC-1 can stimulate the expression of
activation was compared to the value observed in cells transfected
several key genes of mitochondrial function and adap-with the same vectors but not treated with ligand.
tive thermogenesis, even when expressed at levels far(D) Transcriptional activity function of PGC-1 linked to GAL4 DBD.
below those seen in cold-exposed animals.The full-length PGC-1 was fused in-frame to the DNA-binding do-
main of GAL4. This was expressed in cells with pCMX vector, along Finally, the ability of PGC-1 to affect the expression
with a control fusion between GAL4 DBD and full-length murine of mRNA for a protein (COX-II) encoded in the mitochon-
SRC1. Transcription was assayed with a reporter plasmid containing drial genome suggests that PGC-1 could affect the bio-
five copies of the UAS linked to CAT. The activity stimulated by 4.5
genesis of mitochondria per se. Changes in the cellularmg of the DBD-PGC-1 was set as 100%.
content of mitochondrial DNA have been used as a sim-
ple biochemical assay for mitochondrial proliferation
(Martin et al., 1995; Klingenspor et al., 1996). As shown9-cis retinoic acid and 8-bromo cyclic AMP is particu-
larly striking (14-fold), while all three agents together by Southern blot in Figure 8B, cells expressing PGC-1
have twice the mitochondrial DNA content compared tocause an 18-fold increase above the untreated control.
The data shown above do not indicate whether PGC-1 control cells. The same blots were also probed with
Thermogenic Coactivator of Nuclear Receptors
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These accessory proteins, termed coactivators and co-
repressors, appear to mediate gene activation or gene
repression at promoters even quite distant from the
binding sites for the nuclear receptors (Chakravarti et
al., 1996; Glass et al., 1997; Shibata et al., 1997). Some
examples of ligand-dependent coactivators are SRC-1/
TIFa (Onate et al., 1995), TIF-2 (Voegel et al., 1996), CBP/
p300 (Chakravarti et al., 1996; Kamei et al., 1996), RIP140
(Cavailles et al., 1995), ACTR (Chen et al., 1997), and
PBP (Zhu et al., 1997).
Despite the high degree of specificity in the biological
processes influenced or controlled by particular nuclear
receptors, most of the coactivators or corepressors de-
scribed to date have very little specificity in terms of
where and when they are expressed, or the nuclear
receptors with which they interact. There may also be
many new coactivators still to be discovered whose
expression is regulated spatially or temporally, or that
have selectivity with respect to the receptors with which
they interact. In the category of nuclear receptor coacti-
vators, one coactivator (termed AIB or SRC-3) has re-
cently been described that is overexpressed in many
human breast cancers and increases the transcriptional
activity of the estrogen receptor (Anzick et al., 1997). A
small number of coactivators have been described for
transcription factors outside the nuclear receptor family
that are regulated in a tissue-selective fashion, including
Figure 8. Ectopic Expression of PGC-1 InducesMitochondrial Gene Bob1/OCA-B/OBF1 in B limphocytes (Luo, et al., 1992)
Expression and Increased Mitochondrial DNA and TRF in the Drosophila nervous system and gonads
3T3F442A preadipose cells were infected with a control pBabe ret- (Hansen et al., 1997).
roviral vector or one expressing PGC-1. Cells were differentiated The data presented here show that PGC-1 is unusual
under standard conditions for 6 days when 80%±90% of cells
among known nuclear receptor coactivators in that itsshowed an adipocyte phenotype. Cells were then treated for 4 days
expression isdramatically regulated with respect to bothin medium containg 10% cosmic calf serum, 17 nM insulin, and 10
tissue selectivity and the physiological state of the ani-or 100 nM T3. To induce Ucp-1 gene expression, 9-cis-retinoic acid
(1 mM) and 8-Br-cAMP (1 mM) were added for 24 and 6 hr, respec- mal. The expression of PGC-1 in BAT but not WAT distin-
tively. After these treatments, total RNA was isolated and analyzed. guishes it from most known transcriptional components
(A) RNA blot analysis for UCP-1, COX-II, COX-IV, and ATP synthe- in these tissues and its induction by cold is even more
tase. Probes and hybridization were as in Figure 5. Control hybridiza-
dramatic than that observed for UCP-1. PGC-1 is alsotion with cDNAs for aP2 and the ribosomal protein 36B4 are shown
distinct from the known coactivators in that it appearsin the bottom panel.
(B) Southern blot analysis of mitochondrial genome DNA. 3T3-F442A to use different sequence motifs for protein±protein
cells were differentiated as in (A). Total cellular DNA was isolated docking, on both sides of the receptor±coactivator pair.
(Maniatis et al., 1989) and was digested with Nco I. Ten micrograms Nearly all of the known coactivators and corepressors
of DNA was electrophoresed, and the Southern blot was hybridized
utilize LXXLL sequences to bind at the ligand-regulatedusing COX-II cDNA as a probe for mitochondrial DNA. The blot was
helix 12 in the carboxy terminal AF-2 domain (Heery etthen stripped and hybridized with the nuclear gene 36B4. Duplicate
samples of DNA from cells containing empty vector (2) or PGC-1 al., 1997; Torchia et al., 1997). In contrast, PGC-1 utilizes
(1) are shown. a domain rich in proline residues to bind to a region that
overlaps the DNA binding and hinge region of PPARg.
For PPARg, this opens the possibility that PGC-1 is not
an alternative coactivator to one or more of the ligand-cDNA for 36B4, a ribosomal protein encoded in the nu-
controlled coactivators but, rather, may bind in concertcleus. These results show that ectopic PGC-1 expres-
with these proteins to give a larger macromolecularsion can stimulate an increase in mitochondrial DNA,
indicating an increased biogenesis of mitochondria. complex. On the other hand, ligand-dependent docking
is seen with some other receptors such as the retinoic
acid receptor, the estrogen receptor, and to a certainDiscussion
degree, the thyroid receptor. Since PGC-1 has one
LXXLL sequence, a motif shown in several contexts toThe nuclear receptor superfamily, now known to be com-
be both necessary and sufficient for ligand-dependentprised of more than 100 members, controls an amazing
receptor docking, it is entirely possible that the bindingarray of physiological processes in metazoan organisms.
of PGC-1 to those receptors will depend on this se-Recent research has demonstrated that the nuclear re-
quence and the receptor AF-2 domains.ceptors function by serving as platforms for the assem-
It is now appreciated that most of the coactivators orbly of other important transcriptional components into
macromolecular complexes at specific DNA sequences. corepressors that bind to receptors at AF-2 domains
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carry either histone acetyltransferase or histone deace- can induce PGC-1 expression, as shown in Figure 5. Sec-
ond, cyclic AMP (the intracellular mediator of b-adren-tylase activities (Pazin and Kadonaga, 1997). These ac-
ergic receptor activity) increases the transcriptional ac-tivities may be intrinsic to certain coactivators such CBP
tivity mediated by PGC-1 when expression is drivenand SRC-1 (Bannister and Kouzarides, 1996; Spencer
ectopically, as shown in Figure 7C. While the molecularet al., 1997) or reside in proteins that form complexes
basis of this is not known, the presence of three consen-with corepressors, as illustrated by the complex be-
sus phosphorylation sites for protein kinase A suggeststween SMRT and mammalian histone deacetylase (Nagy
that the protein may be posttranslationally activated byet al., 1997; Torchia et al., 1997). Based on primary se-
this pathway. The thermogenic effects of thyroid hor-quence data, PGC-1 does not contain any motifs that
mone and its receptors are well known. One of the clear-would besuggestive of histone acetylase or deacetylase
est effects of increasing thyroid hormone levels is theactivity. It also has no significant sequence homologies
stimulation of mitochondrial respiration rates in skeletalwith any of the known nuclear receptor coactivators
muscle, brown fat, heart, and kidney. Abnormally lowor corepressors. It may be noteworthy that PGC-1 has
respiration rates, characteristic of a hypothyroid state,paired SR and RNA-binding domains that have been
can be increased by raising thyroid hormone levels (Pil-identified in a number of proteins, including several that
lar and Seitz, 1997). Based on the tissues where it isbind to the regulatory carboxy terminal domain (CTD)
expressed and its ability to coactivate the TR, PGC-1of RNA polymerase II (Yuryev et al., 1996). Whether PGC-1
appears to be a very good candidate to mediate somecan recruit RNA pol II into nuclear receptor complexes or
of these effects.has some other positive action on the gene transcription
Recent evidence has also suggested interesting ef-machinery remains to be determined. Of course, the
fects of the TZDs in thermogenesis. These PPARg li-data presented here could also be explained by PGC-1
gands can increase energy expenditure when givenrelieving a gene repression mechanism. The hinge re-
systemically to rodents, perhaps due to increased for-gion of at least one nuclear receptor (TR) has been
mation of brown fat and an increase in Ucp-1 geneshown to be involved in binding a corepressor (N-CoR;
expression. These effects have also been seen in cul-Horlein et al., 1995). Hence, it is possible that an impor-
tured cells (Foellmi-Adams et al., 1996; Tai et al., 1996;tant part of PGC-1's action may be to derepress tran-
P. P. and B. M. S., unpublished data). The ability ofscription by interfering with corepressor binding. Re-
PGC-1 tocoactivate the function of PPARg onthe UCP-1gardless of its biochemical activity, it seems highly likely
promoter, and presumably other promoters in thermo-that PGC-1 will be a coactivator that falls outside of the
genic pathways, may provide some explanation forcurrent paradigm of ligand-dependent AF-2±docking
these effects.proteins.
In addition to these associations described above,Adaptive thermogenesis refers to a component of en-
ectopic expression experiments presented here showergy expenditure, which is separate from physical activ-
more directly that PGC-1 can regulate components ofity and which can be elevated in response to changing
thermogenesis. At a cellular and molecular level, adap-environmental conditions, most notably cold exposure
tive thermogenesis consists of at least three separableand overfeeding (Himms-Hagen, 1989). Although there
processes: the biogenesis of mitochondria, the expres-has been little progress in understanding the molecular
sion of the mitochondrial enzymes of the respiratorycontrol of adaptive thermogenesis, there is considerable
chain, and the expression of specific uncoupling pro-interest in this subject because of its potential roles in
teins. There are now three known members of the Ucpboth the pathogenesis and therapy of human obesity.
gene family: Ucp-1, expressed exclusively in brown fat;A role for PGC-1 in adaptive thermogenesis is indi-
Ucp-2, expressed widely, and Ucp-3, expressed primar-
cated first by its connection to the key tissues and
ily in skeletal muscle and brown fat. Depending on the
hormones implicated in this process. Our current un-
length of time and severity of a given physiological chal-
derstanding suggests an especially important role for
lenge, one or more of these aspects of thermogenesis
skeletal muscle and brown fat. PGC-1 is induced by may be affected in muscle, BAT, or other tissues.
cold exposure in both muscle and brown fat but not in In our initial experiments, we have used retroviral ex-
other tissues. The thermogenic and antiobesity proper- pression of PGC-1 in white fat cells. This cell type was
ties of brown fat are conclusively established in rodents chosen because it has little endogenous PGC-1 expres-
(Himms-Hagen, 1995), but the role of BAT is less clear sion and is known to have relatively low numbers of
in humans due to the fact that adult humans and other mitochondria and little expression of UCP-1 or UCP-3.
large mammals do not have well-defined brown fat de- Although we were only able to get a relatively low level
pots. The expression of UCP-1 in the white fat depots of PGC-1 mRNA expression (6% of that seen in cold-
of adults suggests that brown adipocytes may be incor- induced BAT), it is clear that several molecular compo-
porated into depots that appear white and can be re- nents of the adaptive thermogenesis system are altered.
cruited upon adrenergic stimulation (Garruti and Ric- First, expression of the Ucp-1 gene is turned on from
quier, 1992). the almost undetectable level that is characteristic of
With regard to hormones, thyroidhormone and b-adren- these white cells. Second, several mitochondrial genes
ergic agonists appear to play the most important roles of the respiratory chain that are ordinarily expressed in
in both cold and diet-induced thermogenesis in muscle these cells, such as ATP synthetase, Cox-II and Cox-IV,
and brown fat (Himms-Hagen, 1989; Cannonand Neder- are significantly increased. Finally, mitochondrial con-
gaard, 1996). b-adrenergic agonists appear to affect tent is doubled, as evidenced by the increase in mito-
chondrial DNA per unit of total cellular DNA. AlthoughPGC-1 function in at least two distinct ways. First, they
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phage clones were excised into pBluescript and both strands werenot shown here, we have been unable to detect any
sequenced by standard methods.increases in the expression of UCP-2 or UCP-3 in these
cells. UCP-3 is of special interest because its tissue
Protein Binding and Cellular Localization Studies
major sites of synthesis (muscle, BAT; Vidal-Puig et PGC-1 (EcoRI-XhoI fragment from pBluescript) was cloned into the
al., 1997), and hormones that are reported to induce it SmaI site of pGEX 5X3. The PPARg deletions were generated by
(b-adrenergic agonists and thyroid hormone; Gong et performing PCR using specific oligonucleotides and there were
cloned in-frame in pGEX 5X2. These fusionproteins were expressed,al., 1997) fit very well with the expression patterns and
and purified from E. coli on beads containing glutathione. Of 50%activities of PGC-1. The inability to elevate UCP-3 in the
slurry beads containing approximately 1 mg of protein (either GST,experiments may represent a strict limitation on the cell
or alone, or fused to PGC-1), 30 ml was resuspended in the binding
types that are permissive for UCP-3 expression, the fact buffer (20 mM HEPES [pH 7.7], 75 mM KCl, 0.1 mM EDTA, 2.5 mM
that we have so far attained an insufficient quantity of MgCl2, 0.05% NP40, 2 mM DTT, 10% glycerol). This was mixed with
PGC-1 expression, or the lack of a role for this coactiva- 5 ml of different nuclear receptors made in an in vitro reticulocyte
translation reaction using [35S] methionine (Promega TNT reticulo-tor in the regulation of UCP-3.
cyte lysate system kit). Specific nuclear receptor ligands or vehicleHow might PGC-1 regulate mitochondrial processes
(5 ml) was added as described in the figure legends. Binding waslinked to adaptive thermogenesis? For genes such as
performed for 60 min at room temperature. The beads were then
UCP-1 that are encoded in the nucleus and are respon- washed four times with the binding buffer with or without ligands and
sive to PPAR, TR, or other nuclear receptors, PGC-1 resuspended in SDS-PAGE sample buffer. After electrophoresis,
could act directly as a coactivator to increase transcrip- fixation, and enhancement, the radiolabeled proteins were visual-
ized by autoradiography.tion rates. For genes that are encoded in the mitochon-
Full-length PGC-1 with an HA-tagged N terminus was generateddrial genome (such as Cox-II), PGC-1 could be acting
by PCR and cloned into SmaI of pSV-SPORT. Cell extracts anddirectly or indirectly. Certain genes within the mitochon-
immunoprecipitation from transfected cells were done as in Lassar
dria have been shown to have functional thyroid re- et al. (1991). Rabbit anti-murine PPARg ( Hu et al., 1996) was used
sponse elements (TREs; Pillar and Seitz, 1997). While as a 1:500 dilution for immunoprecipitation. An anti-HA mouse
we show here that PGC-1 is observed mainly in the monoclonal antibody (Boehringer Mannheim) was used at 1:200
dilution for Western blot that was developed using ECL (Amersham).nucleus (Figure 2C), a small percentage of the TR and
GFP fused to the full-length PGC-1 was generated by cloning thisPGC-1 are transported into the mitochondria and func-
coactivator in-frame into the SalI and BamHI sites of pEGFP-C1tion directly at these sites. Similarly, with regard to mito-
(Clontech). Cellular localization was visualized 24 hr after transfec-
chondrial DNA replication, the D loop of the mitochon- tion using a Nikon Diaphora 200 microscope.
drial genome is a site of heavy strand replication and
contains a TRE-DR2 sequence (Wrutniak et al., 1995), Transcriptional Activation Assays
An expression plasmid for full-length PGC-1 was constructed bysuggesting that the TR and PGC-1 could act here di-
first ligating the entire 3 kb cDNA as a SmaI-XhoI fragment intorectly. On the other hand, PGC-1 and nuclear receptors
SmaI-SalI sites of pSV-SPORT (GIBCO-BRL). The 23740/1110 bpcould regulate the expression of other nuclear factors,
UCP promoter was described previously (Kozak et al., 1994). Rat1such as NRF or mitochondrial factor A, that have been
IR fibroblasts were cultured in DMEM containing 10% cosmic calf
shown to function in the mitochondria to stimulate gene serum and transfected at 80%±90% confluence by the calcium
transcription and/or DNA replication (Pillar and Seitz, phosphate method. Ligands were dissolved in a vehicle containing
0.1% DMSO (9-cis retinoic acid and troglitazone) or water (8-bromo-1997).
cAMP). Transfections were performed in duplicate and repeated atA full accounting of the role of PGC-1 in adaptive
least three times. CAT activity was assayed as described (Kim andthermogenesis and perhaps other physiological pro-
Spiegelman, 1996).cesses will require both genetic gain-of-function and
For GAL4 fusion constructs, full-length PGC-1 generated by PCR
loss-of-function experiments in mice. A more detailed was cloned in-frame into the SalI-EcoRV sites of pCMX-GAL4 plas-
knowledge about the function and regulation of PGC-1 mid. Murine full-length SRC-1 was cloned into the SmaI site of
RSV.GAL4. COS cells were transfected in the same way as Rat1 IRcould provide new opportunities to manipulate energy
fibroblasts and the reporter was the 5xUASg-CAT.expenditure invivo and treatdisorders of energy homeo-
stasis such as obesity and obesity-linked diabetes.
Northern and Southern Blot Analysis
Total RNA was isolated from cultured cells and tissues of mouse
by guanidine isothiocyanate extraction. RNA samples were pro-Experimental Procedures
cessed as previously described (Tontonoz et al., 1994b). For South-
ern blot, genomic DNA was isolated and processed from cells asYeast Two-Hybrid System and cDNA Cloning
described (Maniatis et al., 1989).Amino acids 183±505 of the murine PPARg were cloned in-frame
into the GAL4 DNA-binding domain plasmid pAS2. A HIB 1B cDNA
expression library was constructed in the GAL4 activation domain Cell Culture, Retroviral Infection, and Differentiation
The PGC-1 viral expression vector (pBabe-PGC-1) was constructedplasmid pACT II. Yeast two-hybrid screening was performed as
described in the CLONTECH Matchmaker two-hybrid system proto- by ligating the BamHI-XhoI fragment from pBluescript-PGC-1 plas-
mid into BamHI/SalI sites of pBabe-puro (Pear et al., 1993). Follow-col. pAS-PPARg was transformed into Y190 yeast cells by the lithium
acetate method and maintained by selection in leucine2 plates. A ing drug selection, virally infected 3T3F442A-PGC-1 and 3T3F442A-
vector cell lines were grown to confluence in DMEM with 10% BCS.pACT-HIB 1B cDNA library was constructed using isoproterenol-
treated differentiated HIB 1B cells. The pACT II-HIB 1B cDNA library Differentiation of these cells was initiated by culturing them in DMEM
containing 10% cosmic calf serum (CCS, Hyclone) and 850 nMwas transformed into Y190-PPARg yeast cells, and positive clones
were assayed for b-galactosidase activity in a filter assay as de- insulin. They were refed every 2 days with this medium. Specific
treatments of the cells are indicated in the figure legends. HIB-1Bscribed in the CLONTECH protocol. pAS1 lamin cDNA was used to
test the specificity of interaction between PGC-1 and PPARg. To cells were grown in DMEM with 10% CCS to confluence. They were
then treated with 1 mM dexamethasone, 0.5 mM of methyl-isobutyl-obtain full-length PGC-1, the positive yeast cDNA clone was used
as a probe to screen a oligo dT lZAP cDNA library from HIB 1B xanthine, 125 mM indomethacin, 17 nM insulin, and 1 nM T3 for 48
hr to induce differentiation. Cells were subsequently maintainedcells. After three rounds of screening, the cDNA inserts of positive
Cell
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in DMEM containing 10% CCS, 17 nM insulin, and 1 nM T3 and Flier, J.S., and Lowell, B.B. (1997). Obesity research springs a proton
leak. Nat. Genet. 15, 223±224.replenished every 2 days.
Foellmi-Adams, L.A., Wyse, B.M., Herron, D., Nedergaard, J., and
Kletzien, R.F. (1996). Induction of uncoupling protein in brown adi-Animal Protocols
Four-week-old male C57BL/6J mice were used in animal experi- pose tissue. Synergy between norepinephrine and pioglitazone, an
insulin-sensitizing agent. Biochem. Pharmacol. 52, 693±701.ments. These were fed ad libitum and 10 animals were grouped per
cage. A control group was kept at 248C, while experimental groups Garruti, G., and Ricquier, D. (1992). Analysis of uncoupling protein
were kept at 48C for 3 or 12 hr. Animals were sacrificed and tissues and its mRNA in adipose tissue deposits of adult humans. Int. J.
were dissected and collected immediately. Obes. Relat. Metab. Disord. 16, 383±390.
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